Famotidine in Covid-19 Intensive Care Unit

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

August 15, 2021

Conditions

COVID-19 Pandemic

Interventions

DRUG

Famotidine Tablets

160 mg/day Famotidine

Trial Locations (1)

Istanbul Medeniyet University, Istanbul

All Listed Sponsors

lead

Istanbul Medeniyet University

OTHER

NCT05122208 - Famotidine in Covid-19 Intensive Care Unit | Biotech Hunter | Biotech Hunter